Figure 8.
Change at week 56 in radiographic end-points in TNF inadequate-response patients treated
with rituximab. *P = 0.011, **P = 0.005, ***P < 0.001. Reproduced from Keystone et al. Arthritis Rheum 2008, 59: 785–793 [48], with permission from BMJ Publishing Group Ltd. TNF, tumour necrosis factor.
Rubbert-Roth and Finckh Arthritis Research & Therapy 2009 11(Suppl 1):S1 doi:10.1186/ar2666 |
